At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Observational Study to Characterize Patient Global Impression Questions for Activity-induced Symptoms in Patients With Pulmonary Arterial Hypertension (PAH)
In Brief
An observational study evaluating Treprostinil and Non-Treprostinil PAH Medications for Pulmonary Arterial Hypertension. Completed, enrolled 43 participants across 10 sites.
Detailed Summary
This is an observational, multicenter, single-day, Phase 2 study. This study will include a 14-day Screening Period and Study Day 1 clinic visit. Participants will be required to perform an activity to induce symptoms of PAH, and participants' severity of self-reported symptoms of PAH will be measured from pre-activity, immediately after the activity, and through the 30-minute recovery. Participants will be asked about their PAH symptoms using 3 PGI-S questions that address their overall PAH symptoms, shortness of breath, and physical fatigue.
Study Details
Timeline
Interventions
Treprostinil treatment will be at the discretion of the participant's physician, and determined on an individual basis.
Non-treprostinil treatment will be at the discretion of the participant's physician, and determined on an individual basis.